269 related articles for article (PubMed ID: 10930360)
21. MTRR and MTHFR polymorphism: link to Down syndrome?
O'Leary VB; Parle-McDermott A; Molloy AM; Kirke PN; Johnson Z; Conley M; Scott JM; Mills JL
Am J Med Genet; 2002 Jan; 107(2):151-5. PubMed ID: 11807890
[TBL] [Abstract][Full Text] [Related]
22. Association of maternal polymorphisms in folate metabolizing genes with chromosome damage and risk of Down syndrome offspring.
Coppedè F; Migheli F; Bargagna S; Siciliano G; Antonucci I; Stuppia L; Palka G; Migliore L
Neurosci Lett; 2009 Jan; 449(1):15-9. PubMed ID: 18983896
[TBL] [Abstract][Full Text] [Related]
23. Neural tube defects and folate pathway genes: family-based association tests of gene-gene and gene-environment interactions.
Boyles AL; Billups AV; Deak KL; Siegel DG; Mehltretter L; Slifer SH; Bassuk AG; Kessler JA; Reed MC; Nijhout HF; George TM; Enterline DS; Gilbert JR; Speer MC;
Environ Health Perspect; 2006 Oct; 114(10):1547-52. PubMed ID: 17035141
[TBL] [Abstract][Full Text] [Related]
24. Methionine synthase (MTR) 2756 (A --> G) polymorphism, double heterozygosity methionine synthase 2756 AG/methionine synthase reductase (MTRR) 66 AG, and elevated homocysteinemia are three risk factors for having a child with Down syndrome.
Bosco P; Guéant-Rodriguez RM; Anello G; Barone C; Namour F; Caraci F; Romano A; Romano C; Guéant JL
Am J Med Genet A; 2003 Sep; 121A(3):219-24. PubMed ID: 12923861
[TBL] [Abstract][Full Text] [Related]
25. Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification.
Goyette P; Sumner JS; Milos R; Duncan AM; Rosenblatt DS; Matthews RG; Rozen R
Nat Genet; 1994 Jun; 7(2):195-200. PubMed ID: 7920641
[TBL] [Abstract][Full Text] [Related]
26. Absence of association of fetal MTHFR C677T polymorphism with prenatal Down syndrome pregnancies.
Yanamandra K; Bocchini JA; Thurmon TF
Eur J Hum Genet; 2003 Jan; 11(1):5. PubMed ID: 12529699
[No Abstract] [Full Text] [Related]
27. C677T mutation in the 5,10-MTHFR gene and risk of Down syndrome in Italy.
Stuppia L; Gatta V; Gaspari AR; Antonucci I; Morizio E; Calabrese G; Palka G
Eur J Hum Genet; 2002 Jun; 10(6):388-90. PubMed ID: 12080391
[TBL] [Abstract][Full Text] [Related]
28. Polymorphisms within methotrexate pathway genes: Relationship between plasma methotrexate levels, toxicity experienced and outcome in pediatric acute lymphoblastic leukemia.
Esmaili MA; Kazemi A; Faranoush M; Mellstedt H; Zaker F; Safa M; Mehrvar N; Rezvany MR
Iran J Basic Med Sci; 2020 Jun; 23(6):800-809. PubMed ID: 32695297
[TBL] [Abstract][Full Text] [Related]
29. Polymorphisms of SLC19A1 80 G>A, MTHFR 677 C>T, and Tandem TS Repeats Influence Pharmacokinetics, Acute Liver Toxicity, and Vomiting in Children With Acute Lymphoblastic Leukemia Treated With High Doses of Methotrexate.
Cwiklinska M; Czogala M; Kwiecinska K; Madetko-Talowska A; Szafarz M; Pawinska K; Wieczorek A; Klekawka T; Rej M; Stepien K; Halubiec P; Lazarczyk A; Miklusiak K; Bik-Multanowski M; Balwierz W; Skoczen S
Front Pediatr; 2020; 8():307. PubMed ID: 32612964
[No Abstract] [Full Text] [Related]
30. Association of
Razali RH; Noorizhab MNF; Jamari H; James RJ; Teh KH; Ibrahim HM; Teh LK; Salleh MZ
Pediatr Hematol Oncol; 2020 Apr; 37(3):185-197. PubMed ID: 31870219
[TBL] [Abstract][Full Text] [Related]
31. Folate pathway genetic polymorphisms modulate methotrexate-induced toxicity in childhood acute lymphoblastic leukemia.
Yousef AM; Farhad R; Alshamaseen D; Alsheikh A; Zawiah M; Kadi T
Cancer Chemother Pharmacol; 2019 Apr; 83(4):755-762. PubMed ID: 30684021
[TBL] [Abstract][Full Text] [Related]
32. Use of MTHFR C677T polymorphism and plasma pharmacokinetics to predict methotrexate toxicity in patients with acute lymphoblastic leukemia.
Mahmoud LB; Mdhaffar M; Frikha R; Ghozzi H; Hakim A; Sahnoun Z; Elloumi M; Zeghal K
Adv Clin Exp Med; 2018 Aug; 27(8):1061-1068. PubMed ID: 29911750
[TBL] [Abstract][Full Text] [Related]
33. Associations between gene polymorphisms and treatment outcomes of methotrexate in patients with juvenile idiopathic arthritis.
Chen Y; Zou K; Sun J; Yang Y; Liu G
Pharmacogenomics; 2018 Apr; 19(6):529-538. PubMed ID: 29589488
[TBL] [Abstract][Full Text] [Related]
34. Associations between the C677T and A1298C polymorphisms of MTHFR and the toxicity of methotrexate in childhood malignancies: a meta-analysis.
Zhu C; Liu YW; Wang SZ; Li XL; Nie XL; Yu XT; Zhao LB; Wang XL
Pharmacogenomics J; 2018 May; 18(3):450-459. PubMed ID: 28696419
[TBL] [Abstract][Full Text] [Related]
35. Are gene polymorphisms related to treatment outcomes of methotrexate in patients with rheumatoid arthritis? A systematic review and meta-analysis.
Chen Y; Zou K; Sun J; Yang Y; Liu G
Pharmacogenomics; 2017 Jan; 18(2):175-195. PubMed ID: 27992285
[TBL] [Abstract][Full Text] [Related]
36. Methotrexate elimination and toxicity: MTHFR 677C>T polymorphism in patients with primary CNS lymphoma treated with high-dose methotrexate.
Choi YJ; Park H; Lee JS; Lee JY; Kim S; Kim TW; Park JS; Kim JE; Yoon DH; Suh C
Hematol Oncol; 2017 Dec; 35(4):504-509. PubMed ID: 27781293
[TBL] [Abstract][Full Text] [Related]
37. Influence of ADORA2A gene polymorphism on leukoencephalopathy risk in MTX-treated pediatric patients affected by hematological malignancies.
Tsujimoto S; Yanagimachi M; Tanoshima R; Urayama KY; Tanaka F; Aida N; Goto H; Ito S
Pediatr Blood Cancer; 2016 Nov; 63(11):1983-9. PubMed ID: 27399166
[TBL] [Abstract][Full Text] [Related]
38. Clinical-pharmacogenetic predictive models for MTX discontinuation due to adverse events in rheumatoid arthritis.
Jenko B; Lusa L; Tomsic M; Praprotnik S; Dolzan V
Pharmacogenomics J; 2017 Oct; 17(5):412-418. PubMed ID: 27217051
[TBL] [Abstract][Full Text] [Related]
39. Influence of genetic polymorphisms in the folate pathway on toxicity after high-dose methotrexate treatment in pediatric osteosarcoma.
Park JA; Shin HY
Blood Res; 2016 Mar; 51(1):50-7. PubMed ID: 27104192
[TBL] [Abstract][Full Text] [Related]
40. Impact of genetic variants of RFC1, DHFR and MTHFR in osteosarcoma patients treated with high-dose methotrexate.
Jabeen S; Holmboe L; Alnæs GI; Andersen AM; Hall KS; Kristensen VN
Pharmacogenomics J; 2015 Oct; 15(5):385-90. PubMed ID: 25778468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
